Trials / Unknown
UnknownNCT00180791
High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood
Treatment Protocol for High-Risk PNET Brain Tumors in Children With Surgery, Sequential Chemotherapy, Conventional and High-Dose With Peripheral Blood Stem Cell Transplantation and Radiation Therapy
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 71 (estimated)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 10 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of the combination of surgery, conventional chemotherapy, sequential high-dose chemotherapy with peripheral blood stem cell transplantation and reduced dose radiation therapy in high-risk PNET brain tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etoposide, carboplatin, melphalan, cisplatin, thiotepa |
Timeline
- Start date
- 2002-07-01
- First posted
- 2005-09-16
- Last updated
- 2007-09-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00180791. Inclusion in this directory is not an endorsement.